Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -681,175 | -378,284 | -204,969 | -2,106,372 | -1,933,294 |
| Depreciation Amortization | 57,670 | 36,610 | 18,958 | 42,552 | 26,885 |
| Income taxes - deferred | N/A | N/A | N/A | -14,609 | N/A |
| Accounts receivable | 21,168 | 15,397 | -526 | 55,024 | 20,521 |
| Accounts payable and accrued liabilities | -4,822 | N/A | 19,080 | -10,844 | N/A |
| Other Working Capital | -12,219 | -10,394 | 1,488 | -37,006 | -29,047 |
| Other Operating Activity | 381,709 | 172,553 | 75,384 | 1,819,057 | 1,767,268 |
| Operating Cash Flow | $-237,669 | $-164,118 | $-90,585 | $-252,198 | $-147,667 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34,355 | -30,048 | -19,441 | -52,271 | -26,516 |
| Net Acquisitions | N/A | N/A | N/A | 74,728 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -3,691 | -13,691 |
| Other Investing Activity | 336 | -590 | 27 | -86,160 | -56,927 |
| Investing Cash Flow | $-34,019 | $-30,638 | $-19,414 | $-67,394 | $-97,134 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -977 | -648 | -322 | -1,237 | -912 |
| Common Stock Issued | 79 | 24 | 12 | 99,543 | N/A |
| Other Financing Activity | -1,686 | -1,645 | -578 | -2,969 | -1,514 |
| Financing Cash Flow | $-2,584 | $-2,269 | $-888 | $95,337 | $-2,426 |
| Exchange Rate Effect | -690 | -495 | -26 | 908 | -191 |
| Beginning Cash Position | 1,369,581 | 1,369,581 | 1,369,581 | 1,592,928 | 1,592,928 |
| End Cash Position | 1,094,619 | 1,172,061 | 1,258,668 | 1,369,581 | 1,345,510 |
| Net Cash Flow | $-274,962 | $-197,520 | $-110,913 | $-223,347 | $-247,418 |
| Free Cash Flow | |||||
| Operating Cash Flow | -237,669 | -164,118 | -90,585 | -252,198 | -147,667 |
| Capital Expenditure | -37,355 | -32,974 | -19,441 | -52,271 | -26,626 |
| Free Cash Flow | -275,024 | -197,092 | -110,026 | -304,469 | -174,293 |